Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Study candidate is undergoing a temporary SCS trial of commercially approved BSC neurostimulator system, per local directions for use (DFU).
Subject signed a valid, EC/IRB-approved informed consent form.
Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law when written informed consent is obtained.
In the clinician best judgment, subject is able to distinguishably describe quality and location of sensation and pain.
You may not be if
Subject meets any contraindication in BSC neurostimulation system local DFU.
Investigator-suspected gross lead migration during the SCS trial period which may preclude the study candidate from receiving adequate SCS therapy.
Subject is currently diagnosed with cognitive impairment, or exhibits any characteristic, that in the clinician's best judgement would limit study candidate's ability to assess and report sensation information.
Subject is currently diagnosed with a physical impairment, or exhibits a condition that would limit study candidate's ability to complete study assessments.
Clareo Health | Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial
